Insulet?s Omnipod? 5 Automated Insulin Delivery System Improves Clinical Outcomes in Type 1 Diabetes

View source version on?businesswire.com:?https://www.businesswire.com/news/home/20210320005001/en/
Investor Relations: Deborah R. Gordon Vice President, Investor Relations (978) 600-7717 dgordon@insulet.com Jason McGorman Principal Investor Relations Analyst (978) 600-7627 jmcgorman@insulet.com Media: Angela Geryak Wiczek Senior Director, Corporate Communications (978) 932-0611 awiczek@insulet.com Source:?Insulet Corporation